Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tipifarnib in Hormone Refractory Prostate Cancer
NCT00005848Phase 2Completed
- Sponsor
- Fox Chase Cancer Center
- Start
- Apr 2000
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tipifarnib in prostate cancer (PCa), sponsored by Fox Chase Cancer Center. Started Apr 2000; status: completed.
02
Drugs
tipifarnib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00005848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005848.